The Foreign Investment Review Board has extended the deadline for ruling on Cosette’s proposed $672 million takeover of Mayne Pharma.
John Holland has persuaded a court to limit an expert determination in a dispute with contractor Downer EDI over the construction of a rollingstock manufacturing facility in Torbanlea, Queensland.
The Takeovers Panel has agreed to hear Mayne Pharma’s latest dispute with Cosette over the US drug maker’s attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
The director of collapsed Shangri-La Construction is personally liable for the $3.2 million in costs of rectification work on external cladding at an apartment complex in southeast Melbourne, a judge has found.
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
In its case accusing Australian Gas Networks of greenwashing with ads promising gas was “becoming renewable”, the consumer regulator is pushing the company to identify who it says had reasonable grounds for the statements.
A tribunal has ordered a defunct builder of a Dandenong apartment complex to pay $2.9 million in damages for a slew of defects and interest on a loan needed to replace combustible cladding.
Leading national firm Corrs Chambers Westgarth is soaring to new heights with brand new Melbourne digs in the country’s tallest office building.
iSignthis and auditor Grant Thornton have each pointed the finger at each other in response to a shareholder class action over the delisted fintech’s 2018 financial statements.